Alkem Laboratories Ltd.
NSE: ALKEM | BSE: 539523
₹5,404.50
₹-97.00
(-1.76%)
As on 22-May-2026IST
Market cap
₹64,633 Cr
Revenue (TTM)
₹14,253 Cr
P/E Ratio
27.3
P/B Ratio
4.6
Div. Yield
0.8 %
Quality Score
8/10
Growth Score
7/10
Valuation Score
4/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹2,371 Cr
-
ROE
19.9 %
-
ROCE
21.6 %
-
Industry P/E
31.45
-
EV/EBITDA
19.1
-
Debt to Equity
0.1
-
Book Value
₹1170.9
-
EPS
₹201
-
Face value
2
-
Shares outstanding
119,565,000
10 Years Aggregate
CFO
₹10,747.07 Cr
EBITDA
₹15,811.68 Cr
Net Profit
₹12,550.63 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Alkem Laboratories
| -1.9 | -5.1 | 0.2 | 0.6 | 17.8 | 12.5 | 15.9 |
|
BSE Healthcare
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Alkem Laboratories
| -1.2 | 10.0 | 73.1 | -17.1 | 22.8 | 40.5 | 3.8 |
|
BSE Mid Cap
| 1.1 | 25.8 | 45.5 | 1.4 | 39.2 | 19.9 | -3.0 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Alkem Laboratories
|
5,404.5 | 64,633.3 | 14,252.7 | 2,424.5 | 17.5 | 19 | 27.3 | 4.6 |
| 27,830.0 | 59,122.3 | 6,929.1 | 1,552.0 | 26.2 | 35.3 | 38.1 | 12.4 | |
| 1,463.5 | 84,272.7 | 33,653.1 | 3,501.5 | 14.9 | 9.7 | 24 | 2.2 | |
| 430.3 | 69,739.6 | 16,927.0 | 368.8 | 8.8 | -0.6 | 180.9 | 2.0 | |
| 2,306.9 | 39,129.4 | 3,821.7 | 1,036.0 | 32.5 | 51.4 | 37.8 | 17.3 | |
| 1,602.1 | 40,640.9 | 9,504.5 | 947.8 | 15.9 | 14.6 | 44.7 | 5.2 | |
| 2,281.8 | 1,04,222.4 | 27,958.0 | 5,355.5 | 26.6 | 27.4 | 19.5 | 4.6 | |
| 2,479.4 | 1,02,422.1 | 14,277.6 | 1,926.4 | 19.1 | 12.8 | 53.5 | 6.3 | |
| 1,844.6 | 4,42,725.3 | 58,462.0 | 11,564.5 | 23.9 | 15.4 | 38.6 | 5.3 | |
| 1,039.0 | 1,04,542.7 | 27,148.4 | 5,026.4 | 21.9 | 20.7 | 20.7 | 3.9 |
Shareholding Pattern
View DetailsNews & Analysis
All News
How did MFs fare as anchor investors?
4 min read•By Kumar Shankar Roy
About Alkem Laboratories
Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active... pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. Alkem Laboratories Limited was incorporated in 1973 and is headquartered in Mumbai, India. Read more
-
Incorporated
1973
-
Chairman
Basudeo N Singh
-
Managing Director
Sandeep Singh
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Alkem Laboratories Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Alkem Laboratories
What is the current share price of Alkem Laboratories Ltd Today?
The share price of Alkem Laboratories Ltd is ₹5,404.50 (NSE) and ₹5,405.70 (BSE) as of 22-May-2026 IST. Alkem Laboratories Ltd has given a return of 17.85% in the last 3 years.
What is the current PB & PE ratio of Alkem Laboratories Ltd?
The P/E ratio of Alkem Laboratories Ltd is 27.26 times as on 22-May-2026, a 13 discount to its peers’ median range of 31.45 times.
The P/B ratio of Alkem Laboratories Ltd is 4.62 times as on 22-May-2026, a 0 premium to its peers’ median range of 4.62 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
26.94
|
4.88
|
|
2024
|
32.89
|
5.74
|
|
2023
|
41.27
|
4.49
|
|
2022
|
26.28
|
5.01
|
|
2021
|
20.91
|
4.49
|
What is the 52 Week High and Low of Alkem Laboratories Ltd?
The 52-week high and low of Alkem Laboratories Ltd are Rs 5,933.50 and Rs 4,716.20 as of 24-May-2026.
What is the market cap of Alkem Laboratories Ltd?
Alkem Laboratories Ltd has a market capitalisation of ₹ 64,633 Cr as on 22-May-2026. As per SEBI classification, it is a Mid Cap company.
Should I invest in Alkem Laboratories Ltd?
Before investing in Alkem Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.